Medical Ethics
RSSArticles
-
Want to Assess Ethics? Clear Standards are a Good Start
As a consultant who helps healthcare organizations with their ethics programs, Ellen Fox, MD, often finds people want to evaluate quality but don’t know where to begin.
-
No Current Standards for Training on Ethics Consults
The Association of Bioethics Program Directors is currently considering standards for healthcare ethics consultation training programs.
-
ASBH to Address Lack of National Standard for Ethics Consultation
The American Society for Bioethics and Humanities is considering developing a national standard for assessment of individuals who perform clinical ethics consultations.
-
Medical Ethics Advisor Spotlights Quality
This month’s issue of Medical Ethics Advisor is a special issue on quality and ethics.
-
The Ethical Question of Denying Children Antibiotics
As IRB members are no doubt aware, public health officials are warning that the overuse and misuse of antibiotics has selected out resistant strains of bacteria all over the globe. As a result, the short-lived miracle of the antibiotic era is at risk of coming to an end.
-
‘Reimagining’ the IRB Model for the 21st Century
The IRB model created to protect human research subjects more than a half-century ago is in danger of being outstripped by technology-driven research and other forces. It must be “reimagined” for the 21st century to provide safe and ethical oversight of rapidly expanding research agenda, the authors of a recently published report argue.
-
Here’s a List of Vulnerable Populations Historically Exploited in U.S. Research Studies
People who are part of vulnerable populations were exploited in the name of research over the years leading up to our current institutional review board and human research protections.
-
Vulnerable Populations are a Cornerstone of Human Research Protections
Historical accounts of the biggest human research scandals of the past two centuries primarily involved vulnerable populations. The list is long and includes orphans, minorities, the disabled, prisoners, and others.
-
The 21st Century Cures Act Easily Passed, But is it Good for Research Protection?
The 21st Century Cures Act's broad popularity and its $4.8 billion in spending for new research at the National Institutes of Health might not offset some of the bill’s problems tied to research protection, some critics say.
-
Digital Pills Raise Informed Consent, Privacy Concerns
The FDA recently declined approval of what would have been the first mass-marketed drug to include an ingestible sensor.